Covis Pharma GmbH
7Patents
7Active
7Granted
47Portfolio score
Filing activity: Aug 13, 2012 → Jan 29, 2024
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US11007150B2 | Pharmaceutical aerosol product for administration by oral or nasal inhalation | Human Necessities | 2 | Active |
| US11154562B2 | Methods of reducing risk of preterm birth | Human Necessities | 2 | Active |
| US11304962B2 | Methods of reducing risk of preterm birth | Human Necessities | 1 | Active |
| US11992556B2 | Pharmaceutical aerosol product for administration by oral or nasal inhalation | Human Necessities | 0 | Active |
| US11730744B2 | Methods of reducing risk of preterm birth | Human Necessities | 0 | Active |
| US12370141B2 | Pharmaceutical aerosol product for administration by oral or nasal inhalation | Human Necessities | 0 | Active |
| US11052042B2 | Aqueous suspensions of ciclesonide for nebulisation | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.